Caris Life Sciences Executive and Leadership Team

Stephanie Thomas, the Executive Vice President & Chief of Staff & Chief Executive Officer, Office of at Caris Life Sciences, directs high-level corporate strategy and operational alignment. Managing the executive office, Thomas coordinates cross-functional initiatives to ensure the organization maintains focus on precision medicine goals. This leadership role involves streamlining communication between departments to accelerate the deployment of diagnostic technologies. By optimizing internal workflows, Stephanie Thomas drives organizational efficiency and supports the broader mission of improving patient lives through data. The Executive Vice President & Chief of Staff & Chief Executive Officer, Office of oversees the integration of research and development outputs into actionable clinical services. Through rigorous oversight of corporate priorities, Thomas ensures that the company remains at the forefront of the biotechnology sector while maintaining operational excellence across all North American market initiatives.

Luke Power, the Senior Vice President, Chief Financial Officer and Chief Accounting Officer at Caris Life Sciences, directs the financial strategy and fiscal health of the organization. Overseeing capital allocation, financial reporting, and accounting standards, Power ensures that the company maintains the resources necessary to fund transformative research and development. This role involves managing investor relations and ensuring compliance with regulatory financial requirements. By optimizing the company's balance sheet, Luke Power drives sustainable growth and supports the expansion of precision medicine services. The Senior Vice President, Chief Financial Officer and Chief Accounting Officer collaborates with the executive team to evaluate the financial viability of new diagnostic technologies and market opportunities. Through disciplined fiscal management, Power secures the long-term stability of the company, enabling the continued pursuit of innovative solutions that provide physicians and patients with critical information about disease.

Valeriy Domenyuk, the Senior Vice President and Chief Technology Officer at Caris Life Sciences, architects the technological infrastructure required for large-scale genomic and proteomic data analysis. Overseeing the development of proprietary diagnostic platforms, Domenyuk ensures that the company utilizes cutting-edge computational tools to provide physicians with high-quality disease information. This role involves managing complex R&D pipelines and integrating machine learning models into clinical workflows. By spearheading innovation in molecular profiling, Valeriy Domenyuk directly impacts the accuracy and speed of precision medicine delivery. The Senior Vice President and Chief Technology Officer collaborates with scientific teams to translate massive datasets into meaningful clinical insights. Through the continuous refinement of technical capabilities, Domenyuk maintains the company's competitive edge in the global biotechnology landscape, ensuring that technological advancements consistently support the overarching goal of enhancing patient care and diagnostic precision.

Cara Ferris, the Chief of Staff, York Office at Caris Life Sciences, manages administrative operations and regional strategic execution. Coordinating daily activities within the York facility, Ferris ensures that organizational resources align with the company's mission of providing high-quality disease information. This leadership position involves facilitating communication between local teams and the broader corporate structure to maintain operational consistency. By optimizing administrative processes, Cara Ferris drives productivity and supports the successful implementation of precision medicine initiatives. The Chief of Staff, York Office monitors performance metrics to ensure that regional outputs meet the rigorous standards required for clinical diagnostics. Through the effective management of internal projects and stakeholder engagement, Ferris secures the operational stability necessary for the company to continue trailblazing the path to precision medicine, ultimately contributing to the long-term success of the organization's research and development efforts.